CAR-T Tx Shifts into First Gear in Lung Cancer
*October 2018* by Shalmali Pal Medpage Today and ASCO Chimeric antigen receptor (CAR) T-cell therapy took a victory lap in early 2018 when it was named the "Advance of the Year" in the ASCO Annual Report. Versions of CAR-T cell therapy have shown promise for extending survival in previously incurable forms of leukemia,